Shares in Senseonics (NYSE:SENS) have fallen slightly today after the continuous glucose monitoring-focused medtech company posted first quarter earnings that missed on earnings per share expectations but beat sales consensus on Wall Street.
The Germantown, Md.-based company posted losses of $22.3 million, or 16¢ per share, on sales of $2.9 million for the three months ended March 31, seeing losses grow 70.4% while sales grew 432.7% compared with the same period during the previous year.
Read the whole story on our sister site, Drug Delivery Business
The post Senseonics Q1 misses on EPS appeared first on MassDevice.